Study Finds More Evidence That Aspirin Could Fight Cancer

May 11, 2011

The Philadelphia Inquirer

Timothy Rebbeck, PhD, a professor of Epidemiology and Biostatistics and associate director for Population Science at the Abramson Cancer Center, is quoted in a Philadelphia Inquirer story about a new study showing that prostate cancer patients who took aspirin were less likely to have a recurrence of their disease. Rebbeck said the idea that aspirin could fight cancer was "plausible and interesting" given the growing focus on inflammation and cancer. But, he said, it's "not completely clear" that aspirin affects any form of cancer. Read More